Franklin Resources
EWTX icon

Franklin Resources’s Edgewise Therapeutics EWTX Stock Holding History

Franklin Resources’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Sell
37,605
-4,121
-10% -$142K ﹤0.01% 2114
2026
Q1 		$1.31M Sell
41,726
-1,419
-3% -$40.9K ﹤0.01% 2077
2025
Q4 		$1.07M Sell
43,145
-5,075
-11% -$102K ﹤0.01% 2046
2025
Q3 		$782K Buy
48,220
+2,414
+5% +$34.2K ﹤0.01% 2229
2025
Q2 		$601K Sell
45,806
-481
-1% -$6.94K ﹤0.01% 2238
2025
Q1 		$1.02M Buy
46,287
+14,680
+46% +$385K ﹤0.01% 1962
2024
Q4 		$844K Sell
31,607
-13,616
-30% -$434K ﹤0.01% 2053
2024
Q3 		$1.44M Buy
45,223
+20,674
+84% +$411K ﹤0.01% 1838
2024
Q2 		$442K Buy
24,549
+4,544
+23% +$79.3K ﹤0.01% 2286
2024
Q1 		$365K Buy
+20,005
New +$318K ﹤0.01% 2395

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources's EWTX Position: Q2 2026 in Review

Franklin Resources reduced its Edgewise Therapeutics (EWTX) stake by 9.9% in Q2 2026, selling an estimated $142K and leaving 37,605 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Franklin Resources first reported a position in EWTX in Q1 2024 and has held it in 10 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Franklin Resources held 37,605 shares of Edgewise Therapeutics worth $1.53M as of Q2 2026.
  • Franklin Resources sold 4,121 Edgewise Therapeutics shares in Q2 2026, an estimated $142K.
  • Edgewise Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2114 holding.
  • Franklin Resources first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.